Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: |
Ibuprofen SR BNM |
Active Ingredient: |
Ibuprofen 800mg |
Dosage Form: |
Modified release tablet |
New Zealand Sponsor: |
Boucher & Muir (New Zealand) Limited t/a BNM Group |
Manufacturer: |
Medreich Limited, Bangalore, India |
|
|
Product: |
Mavenclad |
Active Ingredient: |
Cladribine 10mg |
Dosage Form: |
Tablet |
New Zealand Sponsor: |
Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics |
Manufacturer: |
NerPharMa SRL, Milan, Italy |
|
|
Product: |
Merck Cladribine |
Active Ingredient: |
Cladribine 10mg |
Dosage Form: |
Tablet |
New Zealand Sponsor: |
Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics |
Manufacturer: |
NerPharMa SRL, Milan, Italy |
Dated this 25th day of July 2019.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).